TEE 001
Alternative Names: TEE-001Latest Information Update: 21 Apr 2023
At a glance
- Originator APTEEUS; Institut Pasteur de Lille
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued COVID 2019 infections
Most Recent Events
- 21 Apr 2023 Discontinued - Preclinical for COVID-2019 infections in France (IV) (APTEEUS pipeline, April 2023)
- 06 Jul 2021 Preclinical trials in COVID-2019 infections in France (IV)
- 06 Jul 2021 TEE 001 receives the “National Research Priority” label for COVID-2019 infections from CAPNET in France prior to July 2021